India to United States: Bisacodyl Export Trade Route

The India to United States Bisacodyl corridor is one of India's established pharmaceutical export routes, with 43 shipments documented worth a combined $812.0K USD. The route is dominated by BLISS GVS PHARMA LIMITED, which alone accounts for roughly 84% of all export value, reflecting the consolidated nature of India's bisacodyl manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $18.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with bisacodyl's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #11 among India's top bisacodyl export destinations globally.

On the import side, key buyers of Indian bisacodyl in United States include TO THE ORDER OF, M S GERICARE PHARMACEUTICALS, To The Order and 12 others. TO THE ORDER OF is the single largest importer with 15 shipments valued at $307.0K USD.

India's bisacodyl exports to United States are driven primarily by a handful of large-scale manufacturers. BLISS GVS PHARMA LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BLISS GVS PHARMA LIMITED, TRUECARE BIOMEDIX, ELYSIUM PHARMACEUTICALS LTD — together account for 98% of total trade value on this route. The average shipment value of $18.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumption(bisacodyl suppositories usp 10 mg) other details as per invoicenos and pharmaceutical product bisacodyl suppositories usp 10 mg other details as per invoice, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 15 shipments worth $307.0K USD — representing 38% of all bisacodyl imports from India on this route. A total of 15 buyers are active on this corridor.